State-of-the-Art Emerging Respiratory Viruses in Europe

Dear Colleagues,

The year 2020 saw an unprecedented pandemic outbreak worldwide, caused by a novel member of the viral family Coronaviridae, identified as SARS CoV-2. This novel virus, likely of animal origin, acquired the capability to efficiently infect humans causing a severe acute respiratory syndrome identified by WHO as COVID-19 (coronavirus disease-19). The very first episodes of COVID-19 were reported in December 2019 in the Chinese city of Wuhan (the province of Hubei), Europe, and, in particular, Italy was among the first areas that this novel infection spread with hundreds of thousands of people affected. By the end of 2020, the infection had reached millions of people worldwide, thus becoming the most relevant and devastating pandemic since the Spanish Flu that occurred a century ago. All of this prompted an enormous scientific effort worldwide to increase our knowledge of the virus and the possibility to set up an efficient laboratory and territorial diagnostics workflows, the pathogenesis of COVD-19, the possibility to use effective therapies for COVID-19, and the development of effective strategies to control the diffusion of the pandemic outbreak.

This Special Issue will provide a tool for peer-reviewed dissemination of cutting-edge scientific results obtained in all of the fields related to the identification, clinical picture, treatment, and epidemic control of the infection caused by SARS CoV-2 and related potential emerging respiratory viruses in Europe.

Prof. Dr. Vittorio Sambri
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.